文献速递淋巴瘤

淋巴样ETS结构域转录因子ELF1在经典霍奇金淋巴瘤中反复缺失表达

Expression of ELF1, a lymphoid ETS domain-containing transcription factor, is recurrently lost in classical Hodgkin lymphoma.
PubMed 文献 · Br J Haematol · 2019-01-25

该研究分析ETS结构域转录因子ELF1和ELF2在经典霍奇金淋巴瘤中的(表观)基因组改变及基因和蛋白表达。结果显示HRS细胞中ELF1蛋白缺失或降低见于31/35(89%)病例,cHL细胞系中ELF1 mRNA及蛋白显著下调(P<0·01),ELF2蛋白无反复缺失;ELF1通过杂合性缺失结合剩余等位基因高甲基化(4/7细胞系,57%)及转录起始位点附近DNA高甲基化(7/7细胞系,100%)而表达受损,5/18(28%)原发活检组织携带ELF1杂合性缺失。

要点

  • HRS细胞中ELF1蛋白缺失或降低见于31/35(89%)病例,ELF2蛋白无反复缺失。
  • cHL细胞系中ELF1 mRNA及蛋白水平较非cHL细胞系显著下调(P<0·01)。
  • ELF1表达受损与杂合性缺失及DNA高甲基化相关,可能参与HRS细胞B细胞表型丢失。

核心结论

  • ELF1在cHL中通过遗传和表观遗传改变而表达受损,可能为转录因子网络中另一成员,其下调促成HRS细胞B细胞表型丢失。

研究设计与样本

  • 研究分析ETS结构域转录因子ELF1和ELF2在cHL中的(表观)基因组改变及基因和蛋白表达。
  • 检测样本包括35例cHL病例的HRS细胞、7个cHL细胞系、非cHL细胞系及18例原发活检组织。

主要发现

  • HRS细胞中ELF1蛋白缺失或降低见于31/35(89%)病例, compared to bystander cells;cHL细胞系中ELF1 mRNA及蛋白水平较非cHL细胞系显著下调(P<0·01)。
  • ELF2蛋白无反复缺失。
  • 4/7(57%)细胞系中ELF1存在杂合性缺失合并剩余等位基因高甲基化;7/7(100%)cHL细胞系中ELF1转录起始位点附近检测到DNA高甲基化(范围95-99%,均值98%)。
  • 5/18(28%)分析的原发活检组织携带ELF1杂合性缺失。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Loss of B cell-specific transcription factors (TFs) and the resulting loss of B-cell phenotype of Hodgkin and Reed-Sternberg (HRS) cells is a hallmark of classical Hodgkin lymphoma (cHL). Here we have analysed two members of ETS domain containing TFs, ELF1 and ELF2, regarding (epi)genomic changes as well as gene and protein expression. We observed absence or lower levels of ELF1 protein in HRS cells of 31/35 (89%) cases compared to the bystander cells and significant (P < 0·01) downregulation of the gene on mRNA as well as protein level in cHL compared to non-cHL cell lines. However, no recurrent loss of ELF2 protein was observed. Moreover, ELF1 was targeted by heterozygous deletions combined with hypermethylation of the remaining allele(s) in 4/7 (57%) cell lines. Indeed, DNA hypermethylation (range 95-99%, mean 98%) detected in the vicinity of the ELF1 transcription start site was found in all 7/7 (100%) cHL cell lines. Similarly, 5/18 (28%) analysed primary biopsies carried heterozygous deletions of the gene. We demonstrate that expression of ELF1 is impaired in cHL through genetic and epigenetic alterations, and thus, it may represent an additional member of a TF network whose downregulation contributes to the loss of B-cell phenotype of HRS cells.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Paczkowska J, Soloch N, Bodnar M, et al. Expression of ELF1, a lymphoid ETS domain-containing transcription factor, is recurrently lost in classical Hodgkin lymphoma. Br J Haematol. 2019. PMID: 30681722. doi:10.1111/bjh.15757

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。